Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16756
Country/Region: Namibia
Year: 2017
Main Partner: Ministry of Health and Social Services - Namibia
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $4,461,725 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $72,696
Care: TB/HIV (HVTB) $262,600
Care: Pediatric Care and Support (PDCS) $46,184
Strategic Information (HVSI) $420,023
Health Systems Strengthening (OHSS) $55,056
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $200,003
Testing: HIV Testing and Counseling (HVCT) $631,004
Sexual Prevention: Other Sexual Prevention (HVOP) $314,248
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $435,200
Treatment: Adult Treatment (HTXS) $1,645,605
Treatment: Pediatric Treatment (PDTX) $379,106
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 103,766
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 33,134
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 5
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 159
HTS_TST Service Delivery Point (Facility) VMMC: <15, Negative 2018 224
HTS_TST Service Delivery Point Agg Age (Facility) ANC: 15+, Negative 2018 12,139
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 321
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 223
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 3,712
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 1,161
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 2,170
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 744
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 64
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 61
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 759
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 393
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 4,030
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 2,387
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 37,526
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 25,576
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Female, Negative 2018 7
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Male, Negative 2018 8
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 106
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 115
HTS_TST Service Delivery Point Agg Age (Facility) VMMC: <15, Negative 2018 182
HTS_TST Service Delivery Point Agg Age (Facility) VMMC: 15+, Negative 2018 2,771
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 4,389
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 1,353
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 819
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 13,413
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 7,827
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 15
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 8
HTS_TST Service Delivery Point by Agg Age (Facility) VMMC: 15+, Negative 2018 1,038
HTS_TST Sum of Test Result disaggregates 2018 7,691
HTS_TST Sum of Test Result disaggregates 2018 2,369
HTS_TST_POS By Test Result: Positive 2018 7,691
HTS_TST_POS By Test Result: Positive 2018 2,369
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 3
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: 15+, Positive 2018 852
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 388
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 99
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 260
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 60
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 121
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 56
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 147
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 119
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 3,056
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 1,769
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 19
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point Agg Age (Facility) VMMC: 15+, Positive 2018 209
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 453
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 48
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 36
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 904
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 640
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VMMC: <15, Positive 2018 7
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VMMC: 15+, Positive 2018 32
PMTCT_ART Already on ART at beginning of current pregnancy 2018 2,000
PMTCT_ART Already on ART at beginning of current pregnancy 2018 874
PMTCT_ART New on ART 2018 658
PMTCT_ART New on ART 2018 522
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 2,658
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,396
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 16,755
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 6,152
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 2,454
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,397
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 437
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 209
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,958
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,151
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 40
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 19
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 19
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 18
PMTCT_STAT By Age (Numerator): : 15-19 2018 2,617
PMTCT_STAT By Age (Numerator): 15-19 2018 970
PMTCT_STAT By Age (Numerator): 20-24 2018 4,726
PMTCT_STAT By Age (Numerator): 20-24 2018 1,742
PMTCT_STAT By Age (Numerator): 25-49 2018 9,206
PMTCT_STAT By Age (Numerator): 25-49 2018 3,329
PMTCT_STAT By known positives: 15-19 2018 52
PMTCT_STAT By known positives: 20-24 2018 168
PMTCT_STAT By known positives: 25-49 2018 1,716
PMTCT_STAT By new negatives: 15-19 2018 2,365
PMTCT_STAT By new negatives: 20-24 2018 4,245
PMTCT_STAT By new negatives: 25-49 2018 6,972
PMTCT_STAT By new positives: 15-19 2018 111
PMTCT_STAT By new positives: 20-24 2018 218
PMTCT_STAT By new positives: 25-49 2018 476
PMTCT_STAT By Number of known positives: 15-19 2018 32
PMTCT_STAT By Number of known positives: 20-24 2018 129
PMTCT_STAT By Number of known positives: 25-49 2018 815
PMTCT_STAT By Number of new negative: 15-19 2018 890
PMTCT_STAT By Number of new negative: 20-24 2018 1,512
PMTCT_STAT By Number of new negative: 25-49 2018 2,325
PMTCT_STAT By Number of new positives: 15-19 2018 76
PMTCT_STAT By Number of new positives: 20-24 2018 144
PMTCT_STAT By Number of new positives: 25-49 2018 235
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 16,755
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 6,152
PMTCT_STAT_den By Age (Denominator): <15-19 2018 1,213
PMTCT_STAT_den By Age (Denominator): 15-19 2018 2,933
PMTCT_STAT_den By Age (Denominator): 20-24 2018 5,370
PMTCT_STAT_den By Age (Denominator): 20-24 2018 2,056
PMTCT_STAT_den By Age (Denominator): 25-49 2018 9,016
PMTCT_STAT_den By Age (Denominator): 25-49 2018 3,099
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,143
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 297
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,037
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 274
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 46
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 183
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 18
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 165
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,343
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 510
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 2,437
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 1,117
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 48
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 189
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 21
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 169
TX_CURR Aggregated Age/Sex: <15 Female 2018 2,388
TX_CURR Aggregated Age/Sex: <15 Female 2018 542
TX_CURR Aggregated Age/Sex: <15 Male 2018 1,545
TX_CURR Aggregated Age/Sex: <15 Male 2018 358
TX_CURR Aggregated Age/Sex: 15+ Female 2018 32,542
TX_CURR Aggregated Age/Sex: 15+ Female 2018 10,068
TX_CURR Aggregated Age/Sex: 15+ Male 2018 16,877
TX_CURR Aggregated Age/Sex: 15+ Male 2018 4,668
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 53,360
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 15,636
TX_CURR Sum of Aggregated Age/Sex <15 2018 3,933
TX_CURR Sum of Aggregated Age/Sex <15 2018 900
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 49,419
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 14,736
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 53,352
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 15,636
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 50
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 197
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 36
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 142
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 2,179
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 5,401
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 1,215
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 3,273
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 9,023
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 3,497
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 3,480
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 9,013
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 45,120
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 14,144
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 38,352
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 12,023
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,717
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 389
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,507
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 374
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 24,672
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 8,230
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 10,459
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 3,030
TX_PVLS Numerator: Indication: Routine 2018 38,352
TX_PVLS Numerator: Indication: Routine 2018 12,023
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 2
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,017
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 456
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,774
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 442
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 29,028
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 9,680
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 12,301
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 3,566
TX_PVLS_den Denominator: Indication: Routine 2018 45,095
TX_PVLS_den Denominator: Indication: Routine 2018 14,144
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 90
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 21
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 100
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,993
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 893
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 891
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 321
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 3,075
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 1,239
TX_RET Numerator by Status: Pregnant 2018 9
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 3,905
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 1,628
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 115
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 23
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 132
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,518
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,179
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,140
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 418